Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells

Journal of Controlled Release

Volumn 121, Issue 3, 2007, Pages 208-217

  Peeters, L ^a   Sanders, N N ^a   Jones, A ^b   Demeester, J ^a   De Smedt, S C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Gene therapy; Intravitreal injection; Lipoplexes; Non viral; Pegylation; RPE

Indexed keywords

CELL MEMBRANES; CYTOLOGY; DNA; LIPOSOMES; TISSUE;

GENE THERAPY; INTRAVITREAL INJECTION; LIPOPLEXES; PEGYLATION; RPE;

GENE TRANSFER;

CERAMIDE; LIPOPLEX; LIPOSOME; LUCIFERASE;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENDOSOME; GENE EXPRESSION; GENETIC TRANSFECTION; INTERNALIZATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PIGMENT EPITHELIUM; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANIMALS; CATTLE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; GENE TARGETING; LIPOSOMES; PIGMENT EPITHELIUM OF EYE; POLYETHYLENE GLYCOLS; VEHICLES;

EID: 34547666993     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.05.033     Document Type: Article

References (32)

1. Bainbridge J.W., Tan M.H., and Ali R.R. Gene therapy progress and prospects: the eye. Gene Ther. 13 (2006) 1191-1197
2. Molday R.S. Photoreceptor membrane proteins phototransduction, and retinal degenerative diseases. The Friedenwald Lecture. Invest Ophthalmol. Vis. Sci. 39 (1998) 2491-2513
3. Campochiaro P.A. Retinal and choroidal neovascularization. J. Cell. Physiol 184 (2000) 301-310
4. Bejjani R.A., et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol. Vis. 11 (2005) 124-132
5. Acland G.M., et al. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 28 (2001) 92-95
6. Abul-Hassan K., Walmsley R., and Boulton M. Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells. Curr. Eye Res. 20 (2000) 361-366
7. Chaum E., Hatton M.P., and Stein G. Polyplex-mediated gene transfer into human retinal pigment epithelial cells in vitro. J. Cell. Biochem. 76 (1999) 153-160
8. Ferber D. Gene therapy safer and virus-free?. Science 294 (2001) 1638-1642
9. Li S., and Huang L. Nonviral gene therapy: promises and challenges. Gene Ther. 7 (2000) 31-34
10. Nishikawa M., and Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12 (2001) 861-870
11. Reichel M.B., et al. Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther. 5 (1998) 1038-1046
12. Bloquel C., et al. Non-viral ocular gene therapy: potential ocular therapeutic avenues. Adv. Drug Deliv. Rev. 58 (2006) 1224-1242
13. Duvvuri S., Majumdar S., and Mitra A.K. Drug delivery to the retina: challenges and opportunities. Expert. Opin. Biol. Ther. 3 (2003) 45-56
14. Peeters L., et al. Vitreous: a barrier to nonviral ocular gene therapy. Invest Ophthalmol. Vis. Sci. 46 (2005) 3553-3561
15. Sanders N.N., De Smedt S.C., Cheng S.H., and Demeester J. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. Gene Ther. 9 (2002) 363-371
16. Choi J.H., Choi J.S., Suh H., and Park J.S. Effect of poly(ethylene glycol) grafting on polyethylenimine as a gene transfer vector in vitro. Bull Korean Chem. Soc. 22 (2001) 46-52
17. Deshpande M.C., et al. The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes. J. Control. Release 97 (2004) 143-156
18. Harvie P., Wong F.M., and Bally M.B. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J. Pharm. Sci. 89 (2000) 652-663
19. Shi F., et al. Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem. J. 366 (2002) 333-341
20. Song L.Y., et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim. Biophys. Acta 1558 (2002) 1-13
21. Davis A.A., et al. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol. Vis. Sci. 36 (1995) 955-964
22. Sanders N.N., van Rompaey E., De Smedt S.C., and Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am. J. Respir. Crit Care Med. 164 (2001) 486-493
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
24. Wheeler J.J., et al. Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. 6 (1999) 271-281
25. Meyer O., et al. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. 273 (1998) 15621-15627
26. Audouy S., and Hoekstra D. Cationic lipid-mediated transfection in vitro and in vivo (review). Mol. Membr. Biol. 18 (2001) 129-143
27. Zuhorn I.S., Kalicharan R., and Hoekstra D. Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J. Biol. Chem. 277 (2002) 18021-18028
28. Litzinger D.C., and Huang L. Phosphatidylethanolamine liposomes: drug delivery gene transfer and immunodiagnostic applications. Biochim. Biophys. Acta 1113 (1992) 201-227
29. Koltover I., Salditt T., Radler J.O., and Safinya C.R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281 (1998) 78-81
30. Smisterova J., et al. Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery. J. Biol. Chem. 276 (2001) 47615-47622
31. Hyvonen Z., et al. Dioleoyl phosphatidylethanolamine and PEG-lipid conjugates modify DNA delivery mediated by 1,4-dihydropyridine amphiphiles. J. Control Release 99 (2004) 177-190
32. Pitkanen L., Ruponen M., Nieminen J., and Urtti A. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm. Res. 20 (2003) 576-583